CN103664869A - Synthetic method of raloxifene intermediate - Google Patents

Synthetic method of raloxifene intermediate Download PDF

Info

Publication number
CN103664869A
CN103664869A CN201310705961.8A CN201310705961A CN103664869A CN 103664869 A CN103664869 A CN 103664869A CN 201310705961 A CN201310705961 A CN 201310705961A CN 103664869 A CN103664869 A CN 103664869A
Authority
CN
China
Prior art keywords
compound
raloxifene
synthetic method
reaction
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310705961.8A
Other languages
Chinese (zh)
Inventor
赵九洋
何田
苗华明
蔡亚辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEIHAI DIJIA PHARMACEUTICAL CO., LTD.
Original Assignee
DISHA PHARMACEUTICAL GROUP SHANDONG DISHA PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DISHA PHARMACEUTICAL GROUP SHANDONG DISHA PHARMACEUTICAL Co Ltd filed Critical DISHA PHARMACEUTICAL GROUP SHANDONG DISHA PHARMACEUTICAL Co Ltd
Priority to CN201310705961.8A priority Critical patent/CN103664869A/en
Publication of CN103664869A publication Critical patent/CN103664869A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a preparation method of a raloxifene intermediate 6-methoxy-2-(4-methoxy phenyl)-3-[4-(2-piperidyl ethyoxyl)benzoyl]-benzothieno[b]hydrochloride, namely a compound 2. The method uses Mo(CO)6 as a catalyst for catalyzing a compound 3 and a compound 4 to perform a Friedel-Crafts acylation reaction to synthesize the compound 2. According to the method, Mo(CO)6 is adopted as the catalyst for performing the Friedel-Crafts acylation reaction, the selectivity is good, few side reactions are generated, the reaction yield reaches up to 95%, the HPLC (high performance liquid chromatography) purity of the raloxifene intermediate is 98%, and the needs of subsequent reactions are met.

Description

A kind of synthetic method of raloxifene intermediate
Technical field:
The synthetic method that the present invention relates to a kind of raloxifene intermediate, belongs to field of medicine and chemical technology.
Background of invention:
RALOXIFENE HCL is the s-generation selective estrogen receptor modulators of Lilly Co., Eli.'s research and development, for prevention and treatment osteoporosis and mammary cancer, has following formula chemical structure:
6-methoxyl group-2-(4-p-methoxy-phenyl)-3-[4-(2-piperidyl oxyethyl group) benzoyl]-thionaphthene [b] hydrochloride; it is compound 2; be the synthetic key intermediate of RALOXIFENE HCL, obtain this compound high-purity high-yield and be significant for the synthetic of RALOXIFENE HCL.
Figure BSA0000099303090000012
J.Med.Chem., 1984,27,1057-1066. has reported that Aluminum chloride anhydrous is catalyzer, and compound 3 and compound 4 are prepared compound 2 by friedel-crafts acylation:
Reaction yield is only 65.5%, has the aromatic nucleus of three electron riches due to substrate compounds 4 simultaneously, causes the selectivity of reaction poor, and by product is many, is difficult for purifying.
EP0062503A1 adopts Aluminum chloride anhydrous to carry out friedel-crafts acylation equally, by " one kettle way ", directly obtains hydrochloric acid thunder Lip river former times phenol, and except having the same shortcoming, the metallic aluminium of end product is residual more, and aluminum pollution is serious.
CN1132205, from compound 3 and compound 4s, replaces Aluminum chloride anhydrous with boron trichloride or boron tribromide, by " one pot ", directly obtains hydrochloric acid thunder Lip river former times phenol.Although avoided aluminum pollution, product yield has reached 88%, yet boron trichloride or boron tribromide are expensive, has strong impulse simultaneously, and the moisture absorption is very easily not suitable for suitability for industrialized production:
Figure BSA0000099303090000021
Summary of the invention:
Main purpose of the present invention is to provide raloxifene intermediate 6-methoxyl group-2-(4-p-methoxy-phenyl)-3-[4-(2-piperidyl oxyethyl group) benzoyl of a kind of highly selective, high yield] synthetic method of-thionaphthene [b] hydrochloride.
Technical scheme of the present invention is a kind of 6-methoxyl group-2-(4-p-methoxy-phenyl)-3-[4-(2-piperidyl oxyethyl group) benzoyl]-thionaphthene [b] hydrochloride, the synthetic method of compound 2, is characterized in that,
Figure BSA0000099303090000022
Compound 3 and compound 4 are joined in organic solvent, add hexacarbonylmolybdenum in batches, magnetic agitation reaction, filtration, filtrate are respectively washed once through water, saturated aqueous common salt successively after completion of the reaction, and organic phase is concentrated, the dry target product 2 that obtains.
Technical scheme of the present invention is, reacting selected organic solvent is methylene dichloride, chloroform, 1, one or more mixed solvents in 2-ethylene dichloride, dithiocarbonic anhydride, preferably methylene dichloride or 1,2-ethylene dichloride, solvent load is 8-10 times (mL/g) of compound 3;
Technical scheme of the present invention is that the mol ratio of each reactant consumption is compound 3: compound 4: Mo (CO) 6≈ 1: 1: 0.01-0.04; Temperature of reaction is 5-20 ℃; Reaction times is 0.5-3h.
The invention has the beneficial effects as follows Mo (CO) 6for carrying out friedel-crafts acylation, catalyst compound 3 and compound 4 prepare compound 2, good reaction selectivity, and by product is few, and reaction yield is up to 95%, and product HPLC purity is 98%, meets the needs of subsequent reactions.
Embodiment:
Embodiment 1:
In the reaction flask of 2L, add compound 3 (121.68g, 0.4mol), compound 4 (108.14g, 0.4mol) and methylene dichloride (1200ml), be cooled to 5 ℃, adds Mo (CO) in batches 6(10.56g, 0.04mol), stirring reaction 3h at this temperature.Filter, filtering solid, filtrate is water and saturated aqueous common salt washed twice (300ml * 2) successively, and organic phase obtains light yellow solid through concentrated by rotary evaporation, dries to obtain target product 204.9g for 70 ℃, yield 95.2%, HPLC purity is 99.1%.
Embodiment 2:
In the reaction flask of 500ml, add compound 3 (30.42g, 0.1mol), compound 4 (27.03g, 0.1mol), 1,2-ethylene dichloride (250ml), is cooled to 10 ℃ by system, adds Mo (CO) in batches 6(2.64g, 0.01mol), stirring reaction 2h at this temperature.Filter, filtering solid, filtrate is water and saturated aqueous common salt washed twice (70ml * 2) successively, and organic phase obtains light yellow solid through concentrated by rotary evaporation, dries to obtain target product 52.25g for 70 ℃, yield 97.1%, HPLC purity is 98.3%.
Embodiment 3:
In the reaction flask of 1L, add compound 3 (60.84g, 0.2mol), compound 4 (54.07g, 0.2mol), methylene dichloride (500ml) adds Mo (CO) at 20 ℃ in batches 6(5.28g, 0.02mol), stirring reaction 0.5h at this temperature.Filter, filtering solid, filtrate is water and saturated aqueous common salt washed twice (100ml * 2) successively, and organic phase obtains light yellow solid through concentrated by rotary evaporation, dries to obtain target product 103.96g for 70 ℃, yield 96.6%, HPLC purity is 98.1%.

Claims (5)

1. a raloxifene intermediate 6-methoxyl group-2-(4-p-methoxy-phenyl)-3-[4-(2-piperidyl oxyethyl group) benzoyl]-thionaphthene [b] hydrochloride; it is the synthetic method of compound 2; it is characterized in that; compound 3 and compound 4 react under the effect of catalyzer hexacarbonylmolybdenum; synthetic compound 2
Figure FSA0000099303080000011
2. synthetic method according to claim 1, is characterized in that, the solvent that reacts used is methylene dichloride or 1,2-ethylene dichloride.
3. synthetic method according to claim 1, is characterized in that, compound 3: compound 4: Mo (CO) 6mol ratio be 1: 1: 0.01-0.04.
4. synthetic method according to claim 1, is characterized in that, temperature of reaction is 5-20 ℃.
5. synthetic method according to claim 1, is characterized in that, the reaction times is 0.5-3h.
CN201310705961.8A 2013-12-13 2013-12-13 Synthetic method of raloxifene intermediate Pending CN103664869A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310705961.8A CN103664869A (en) 2013-12-13 2013-12-13 Synthetic method of raloxifene intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310705961.8A CN103664869A (en) 2013-12-13 2013-12-13 Synthetic method of raloxifene intermediate

Publications (1)

Publication Number Publication Date
CN103664869A true CN103664869A (en) 2014-03-26

Family

ID=50303742

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310705961.8A Pending CN103664869A (en) 2013-12-13 2013-12-13 Synthetic method of raloxifene intermediate

Country Status (1)

Country Link
CN (1) CN103664869A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112851634A (en) * 2020-01-03 2021-05-28 江苏美迪克化学品有限公司 Preparation method of raloxifene hydrochloride

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112851634A (en) * 2020-01-03 2021-05-28 江苏美迪克化学品有限公司 Preparation method of raloxifene hydrochloride
CN112851634B (en) * 2020-01-03 2021-11-16 江苏美迪克化学品有限公司 Preparation method of raloxifene hydrochloride

Similar Documents

Publication Publication Date Title
EP2593449B1 (en) Process for the synthesis of benzothiadiazole compounds
CN108659041B (en) Phosphine ligand compound based on tetramethyl spiroindane skeleton, intermediate thereof, preparation method and application
CN101830821B (en) Chemical synthesis method of N-alcoxyloxalyl alanine ester
CN104520275A (en) Process and intermediates for preparing integrase inhibitors
CN110981779B (en) Synthesis method of R-2- (2, 5-difluorophenyl) pyrrolidine
CN103788069B (en) The preparation method of esomeprazole magnesium trihydrate
Karimi et al. Periodic mesoporous silica chloride (PMSCl) as an efficient and recyclable catalyst for the Pechmann reaction
CN107235891B (en) Preparation method of 4-bromocarbazole
CN103664869A (en) Synthetic method of raloxifene intermediate
CN106946648B (en) Fluorene compound and method for producing fluorene compound
CN102491886B (en) Method for synthetizing indanone compound
CN110790925B (en) (R) -TAPP-BINOL-COF polymer, and preparation method and application thereof
CN103553859A (en) Method for preparing amine compound midbody by utilizing amide
CN102993253A (en) Preparation method of 2',3'-bi-O-acetyl-5'-deoxy-5-fulurocytidine
CN104496909A (en) Dicaryon benzimidazole ionic salt as well as preparation method and application thereof
CN111018899B (en) Method for preparing 1, 1-boron alkyne compound by metal catalysis of terminal olefin
CN101973869B (en) Method for synthesis of flurbiprofen
Satam et al. Selective procedure for the conversion of alcohols into alkyl iodides with SO42-/ZrO2 and NaI at room temperature
CN103183680A (en) Method for preparing asenapine
CN102603693A (en) Preparation process of ethyl chromane-4-formate
CN102827019A (en) One group of novel benzene cyclobutane compounds and application of novel benzene cyclobutane compounds in chemical synthesis
CN103709089B (en) One prepares the method for 3-(4 '-chlorobutyl)-5-cyanoindole
CN111302930B (en) Preparation method of p-phenylbutoxy benzoic acid
CN103274996A (en) Method for preparing 3,5,6-trichloropyridin-2-ol sodium by improved one pot process
CN102276487B (en) Preparation method of trimebutine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20151030

Address after: 264400 No. 46, Guangzhou Road, Wendeng Economic Development Zone, Shandong, Weihai

Applicant after: WEIHAI DIJIA PHARMACEUTICAL CO., LTD.

Address before: 264209 No. 196, science and technology road, torch hi tech Industrial Development Zone, Shandong, Weihai

Applicant before: Disha Pharmaceutical Group Shandong Disha Pharmaceutical Co., Ltd.

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140326